ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

21 hedge funds and large institutions have $1.85M invested in Oramed Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 8 closing their positions.

Holders
21
Holders Change
-6
Holders Change %
-22.22%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
5
Closed
8
Calls
$1K
Puts
$20K
Net Calls
-$19K
Net Calls Change
–

Top Buyers

1
Citigroup
1
Citigroup
New York
$43K
2
EMG
2
ETF Managers Group
New Jersey
$86K
3
LTFS
3
Ladenburg Thalmann Financial Services
Florida
$3K
4
TRCT
4
Tower Research Capital (TRC)
New York
$2K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$454K
3
Millennium Management
3
Millennium Management
New York
$0
4
OAM
4
Oxford Asset Management
United Kingdom
$0
5
Group One Trading
5
Group One Trading
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Macquarie Group
26
Macquarie Group
Australia
– -$32K -3,499 Closed
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
– -$15K -1,700 Closed
CA
28
Calton & Associates
Florida
– -$3K -450 Closed
LC
29
Landaas & Company
Wisconsin
– -$2K -230 Closed
1
2